Pedmarqsi Europese Unie - Nederlands - EMA (European Medicines Agency)

pedmarqsi

fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - alle andere therapeutische producten - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.

Fosinoprilnatrium/Hydrochloorthiazide 20/12,5 Teva, tabletten 20/12,5 mg Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

fosinoprilnatrium/hydrochloorthiazide 20/12,5 teva, tabletten 20/12,5 mg

teva pharma b.v. swensweg 5 2031 ga haarlem - fosinopril natrium ; hydrochloorthiazide - tablet - cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; lactose 0-water ; natriumlaurilsulfaat (e 487) ; povidon (e 1201), - fosinopril and diuretics